Insider Trading & Ownership of Matthew Gline

Location: New York, NY
Summary: The estimated net worth of Matthew Gline is at least $502,320,134 dollars as of 17 Dec 2025. Matthew Gline is the CEO, Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $374.78M. Matthew Gline is the Director, 10%+ Owner of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $127.54M.
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Matthew Gline
All Insider Reports: All Insider Reports

Notify me when Matthew Gline files a new Insider Trading report.

Ownership of Matthew Gline

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ROIV	Roivant Sciences Ltd.	CEO, Director	$374,783,916	-$37,673,243	-9.1%	15 Dec 2025
ABUS	Arbutus Biopharma Corp	Director, 10%+ Owner	$127,536,218			24 Feb 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.